Strides Pharma Science Stock Declines -5.22% in Line with Sector Performance

Strides Pharma Science, a midcap pharmaceutical company, saw a decline of -5.22% in its stock on November 4th, 2024. This drop was in line with the overall performance of the sector, as the company underperformed by -4.5%. The stock, which is part of the Momentumnow Stocks on MarketsMOJO since April 3rd, 2024, has been on a downward trend after three consecutive days of gains.

On the day of the decline, Strides Pharma Science's stock touched an intraday low of Rs 1463.7, representing a decrease of -6.62%. However, the stock is still performing well in the long term, with its moving averages higher than the 50-day, 100-day, and 200-day moving averages. It is worth noting that the stock is currently lower than the 5-day and 20-day moving averages.

In comparison to the overall market performance, Strides Pharma Science's stock has underperformed, with a -4.66% decrease compared to the Sensex's -0.89% decline on the same day. However, in the past month, the stock has outperformed the Sensex, with a 3.20% increase compared to the Sensex's -3.27% decline.

Overall, Strides Pharma Science's stock has seen a recent decline, but its long-term performance remains strong. Investors may want to hold onto their shares for now, as suggested by MarketsMOJO's 'Hold' rating for the stock.